Sun, Jan 25, 2015, 7:58 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • viseslinger viseslinger May 8, 2013 11:30 PM Flag

    Hey Maddi -- no news today on: Today @ 4:00 – 5:30 pm Session IV: Case Studies #1 -- Jakafi - Incyte Corporation (ruxolitinib phosphate)

    Case studies are conducted concurrently, and will be repeated on Thursday and Friday. Learners will have the opportunity to attend all three case studies. •Jakafi - Incyte Corporation (ruxolitinib phosphate)
    A kinase inhibitor indicated for treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.

79.90+2.29(+2.95%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.